Schonfeld Strategic Advisors LLC Ultragenyx Pharmaceutical Inc. Transaction History

Schonfeld Strategic Advisors LLC

$15.2 Billion
Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,144,589 shares of RARE stock, worth $37.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,144,589

Previous 567,175 101.81%

Holding current value

$37.9 Million

Previous $20.6 Million 66.95%

% of portfolio

0.23%

Previous 0.17%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$26.31 - $41.44 $15.2 Million - $23.9 Million	577,414 Added 101.81%	1,144,589 $34.4 Million
Q2 2025 Aug 14, 2025	SELL	$31.06 - $39.3 $7.99 Million - $10.1 Million	-257,243 Reduced 31.2%	567,175 $20.6 Million
Q1 2025 May 15, 2025	BUY	$36.21 - $45.78 $2.79 Million - $3.52 Million	76,989 Added 10.3%	824,418 $29.9 Million
Q4 2024 Feb 14, 2025	BUY	$42.07 - $57.72 $14.6 Million - $20 Million	346,596 Added 86.47%	747,429 $31.4 Million
Q3 2024 Nov 14, 2024	SELL	$40.21 - $59.36 $12.7 Million - $18.8 Million	-316,114 Reduced 44.09%	400,833 $22.3 Million

Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $10.3 Million - $14.3 Million	276,149 Added 62.65%	716,947 $29.5 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $4.22 Million - $5.26 Million	97,986 Added 28.58%	440,798 $20.6 Million
Q4 2023 Feb 14, 2024	BUY	$31.73 - $49.19 $10.9 Million - $16.9 Million	342,812 New	342,812 $16.4 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $720,343 - $948,578	19,474 New	19,474 $780,000
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $977,738 - $1.82 Million	21,348 New	21,348 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $712,775 - $849,606	-9,670 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$77.92 - $102.4 $572,945 - $752,947	7,353 Added 317.35%	9,670 $872,000
Q2 2021 Nov 16, 2021	SELL	$92.19 - $115.71 $368,760 - $462,840	-4,000 Reduced 63.32%	2,317 $221,000
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $582,364 - $730,940	6,317 New	6,317 $602,000
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $221,220 - $411,680	-6,545 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.08 - $45.83 $236,143 - $299,957	6,545 New	6,545 $279,000
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $590,750 - $877,229	-13,900 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $208,734 - $282,568	-3,800 Reduced 21.47%	13,900 $883,000
Q1 2019 May 15, 2019	SELL	$39.87 - $69.36 $634,212 - $1.1 Million	-15,907 Reduced 47.33%	17,700 $1.23 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $100,841 - $200,438	-2,593 Reduced 7.16%	33,607 $1.46 Million
Q3 2018 Nov 14, 2018	BUY	$71.81 - $90.15 $2.6 Million - $3.26 Million	36,200 New	36,200 $2.76 Million
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $1.94 Million - $3.42 Million	-40,050 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $1.78 Million - $2.34 Million	40,050 New	40,050 $2.04 Million

Others Institutions Holding RARE

# of Institutions

348

Shares Held

88.2M

Call Options Held

2.19M

Put Options Held

1.04M

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.32B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Ultragenyx Pharmaceutical Inc. Transaction History